| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.077 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.2 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.2 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |